AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Emergent BioSolutions Inc. Director's Dealing 2016

Jul 15, 2016

32870_dirs_2016-07-15_68212a9f-b023-4726-bc72-7c964dd4c46d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2016-07-15

Reporting Person: Emergent BioSolutions Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	1000	Direct